Following President Donald Trump's most favored nation executive order, HHS and CMS have released the target price for ...

President Donald Trump put the biopharma industry on its back foot earlier this month with his executive order on ...

On May 20, the Department of Health and Human Services (HHS) released further details on its plan to implement President ...

President Donald Trump issued an executive order (EO) on May 12, 2025 to address the high cost of prescription drugs in the ...

The U.S. Department of Health and Human Services (HHS) today announced immediate steps to implement President Trump’s ...

The HHS said it has taken the first step toward implementing most-favored-nation pricing for prescription drugs.

The Department of Health and Human Services today announced it has identified specific pricing targets for pharmaceutical ...

HHS is taking “immediate steps” to implement President Donald Trump’s executive order, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients — a key initiative aimed at ...

The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US will pay the same price for a drug as the nation that pays the lowest ...

Signed on May 12, the order aims to enforce most-favored-nation (MFN) pricing by directing the Secretary of Health and Human ...

HHS is taking “immediate steps” to implement President Donald Trump’s executive order, “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients,” a key initiative aimed at ...

Drugmakers will be expected to commit to aligning U.S. prices with the lowest price set in a group of peer nations for all ...